Healthcare - Biotechnology - NASDAQ - US
$ 1.34
-2.9 %
$ 1.93 M
Market Cap
-0.15
P/E
INCOME STATEMENT
0
REVENUE
-12.9 K
OPERATING INCOME
-12.5 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Salarius Pharmaceuticals, Inc.
| Revenue | 0 |
| Cost Of Revenue | 10.1 K |
| Gross Profit | -10.1 K |
| Operating Expenses | 12.9 K |
| Operating Income | -12.9 K |
| Other Expenses | 12.5 M |
| Net Income | -12.5 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 0 | 0 | 1.8 | 5.2 | 3.5 | 0.8 | 1.3 | 1.0 | 0 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 10.1 K | 6.68 K | 19.2 K | 6.91 K | 4.02 K | 0.4 | 0.5 | 0.7 | 49.9 K |
| Gross Profit | 10.1 K | 6.68 K | 1.8 | 5.2 | 3.5 | 0.4 | 0.8 | 0.3 | 49.9 K |
| OPERATING INCOME | |||||||||
| Operating Expenses | 12.9 K | 23.0 | 14.7 | 12.8 | 11.7 | 22.5 | 35.5 | 40.2 | 29.2 |
| Selling, General and Administrative Expenses | 5.72 K | 7.1 | 6.1 | 6.1 | 7.7 | 10.6 | 18.5 | 19.9 | 16.5 |
| Research and Development Expenses | 7.17 K | 15.8 | 8.5 | 6.9 | 4.0 | 11.9 | 17.0 | 20.4 | 12.7 |
| Operating Income | 12.9 K | (31.8) | (12.8) | (7.8) | (9.6) | (22.1) | (34.7) | (39.9) | (29.2) |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 0 | (0.2) | 0 | 3.05 K | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 352 | 0.2 | 44.7 K | 0.4 | 1.3 | 0.2 | 0.3 | 0.4 | 72 K |
| Pre-Tax Income | 12.5 K | (31.6) | (12.8) | (7.4) | (6.9) | (21.9) | (34.4) | (39.5) | (29.1) |
| NET INCOME | |||||||||
| Tax Provision | 0 | (0.2) | 63.9 K | (0.3) | (1.3) | 0.2 | (0.3) | (0.3) | 49.9 K |
| Net Income | 12.5 K | (31.4) | (12.7) | (7.1) | (5.6) | (21.9) | (34.4) | (39.5) | (29.1) |
| EPS | 0.0038 | 14.8 | 7.68 | 11.4 | 42.9 | 760 | 1.25 K | 1.52 K | 1.3 K |